Your browser doesn't support javascript.
loading
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study.
Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Firas, Al-Kaisi; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Anderson, Laura; Chauhan, Saleena Rani; Maddams, Rebecca; Soutar, Richard; Triantafillou, Margarita; Prideaux, Steve; Obeidalla, Abubaker; Eyre, Toby A; Bygrave, Ceri; Basu, Supratik; Ramasamy, Karthik.
Afiliação
  • Djebbari F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Rampotas A; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Vallance G; Oxford University Clinical Academic Graduate School, Oxford, UK.
  • Panitsas F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Basker N; Department of Haematology, Laiko General Hospital, Athens, Greece.
  • Sangha G; University Hospital Southampton, Southampton, UK.
  • Salhan B; Milton Keynes Hospital, Milton Keynes, UK.
  • Karim F; Birmingham Heartlands Hospital, Birmingham, UK.
  • Firas AK; Good Hope Hospital, Birmingham, UK.
  • Gudger A; Solihull Hospital, Solihull, UK.
  • Ngu L; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Poynton M; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Lam HPJ; The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Morgan L; Royal Derby Hospital, Derby, UK.
  • Yang L; Wexham Park Hospital, Slough, UK.
  • Young J; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Walker M; Queen Elizabeth Hospital, Birmingham, UK.
  • Tsagkaraki I; University of Wolverhampton, Wolverhampton, UK.
  • Anderson L; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Chauhan SR; Royal Berkshire Hospital, Reading, UK.
  • Maddams R; Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Soutar R; University Hospital of Wales, Cardiff, UK.
  • Triantafillou M; University Hospitals Sussex NHS Foundation Trust, Sussex, UK.
  • Prideaux S; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Obeidalla A; University Hospital Crosshouse, Crosshouse, UK.
  • Eyre TA; Stoke Mandeville Hospital, Aylesbury, UK.
  • Bygrave C; Royal United Hospital Bath, Bath, UK.
  • Basu S; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Ramasamy K; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
Hematology ; 27(1): 691-699, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35666686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido